About Wenqing Yao
Form D filings for Synnovation Therapeutics from 2021 to 2023 list Wenqing Yao as CEO and director.
Wenqing Yao first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Wenqing Yao in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Wenqing Yao works with at each company, as listed on that company's latest Form D.
Synnovation Therapeutics, Inc. · Form D/A, Dec 21, 2023
